Bio-Rad Laboratories, Inc. BUWA.F Stock
Bio-Rad Laboratories, Inc. Price Chart
Bio-Rad Laboratories, Inc. BUWA.F Financial and Trading Overview
Bio-Rad Laboratories, Inc. stock price | 285 EUR |
Previous Close | 341 EUR |
Open | 343 EUR |
Bid | 343 EUR x 5000 |
Ask | 349.8 EUR x 5000 |
Day's Range | 343 - 343 EUR |
52 Week Range | 331 - 545.6 EUR |
Volume | 4 EUR |
Avg. Volume | 2 EUR |
Market Cap | 10.05B EUR |
Beta (5Y Monthly) | 0.904225 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -20.35 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 856.25 EUR |
BUWA.F Valuation Measures
Enterprise Value | 9.63B EUR |
Trailing P/E | N/A |
Forward P/E | 25.220587 |
PEG Ratio (5 yr expected) | 3.21 |
Price/Sales (ttm) | 3.616814 |
Price/Book (mrq) | 1.0401504 |
Enterprise Value/Revenue | 3.464 |
Enterprise Value/EBITDA | 17.33 |
Trading Information
Bio-Rad Laboratories, Inc. Stock Price History
Beta (5Y Monthly) | 0.904225 |
52-Week Change | -23.90% |
S&P500 52-Week Change | 20.43% |
52 Week High | 545.6 EUR |
52 Week Low | 331 EUR |
50-Day Moving Average | 385.5 EUR |
200-Day Moving Average | 412.71 EUR |
BUWA.F Share Statistics
Avg. Volume (3 month) | 2 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 23.98M |
Float | 21.09M |
Short Ratio | N/A |
% Held by Insiders | 14.52% |
% Held by Institutions | 79.70% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -6.88% |
Operating Margin (ttm) | 14.97% |
Gross Margin | 55.00% |
EBITDA Margin | 19.98% |
Management Effectiveness
Return on Assets (ttm) | 1.85% |
Return on Equity (ttm) | -1.91% |
Income Statement
Revenue (ttm) | 2.78B EUR |
Revenue Per Share (ttm) | 93.57 EUR |
Quarterly Revenue Growth (yoy) | -3.30% |
Gross Profit (ttm) | 1.57B EUR |
EBITDA | 555.52M EUR |
Net Income Avi to Common (ttm) | -191226000 EUR |
Diluted EPS (ttm) | -6.7 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.85B EUR |
Total Cash Per Share (mrq) | 62.53 EUR |
Total Debt (mrq) | 1.38B EUR |
Total Debt/Equity (mrq) | 14.15 EUR |
Current Ratio (mrq) | 5.558 |
Book Value Per Share (mrq) | 329.76 |
Cash Flow Statement
Operating Cash Flow (ttm) | 242.02M EUR |
Levered Free Cash Flow (ttm) | 103.6M EUR |
Profile of Bio-Rad Laboratories, Inc.
Country | Germany |
State | CA |
City | Hercules |
Address | 1000 Alfred Nobel Drive |
ZIP | 94547 |
Phone | 510 724 7000 |
Website | https://www.bio-rad.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 8200 |
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Q&A For Bio-Rad Laboratories, Inc. Stock
What is a current BUWA.F stock price?
Bio-Rad Laboratories, Inc. BUWA.F stock price today per share is 285 EUR.
How to purchase Bio-Rad Laboratories, Inc. stock?
You can buy BUWA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bio-Rad Laboratories, Inc.?
The stock symbol or ticker of Bio-Rad Laboratories, Inc. is BUWA.F.
Which industry does the Bio-Rad Laboratories, Inc. company belong to?
The Bio-Rad Laboratories, Inc. industry is Medical Devices.
How many shares does Bio-Rad Laboratories, Inc. have in circulation?
The max supply of Bio-Rad Laboratories, Inc. shares is 28.66M.
What is Bio-Rad Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?
Bio-Rad Laboratories, Inc. PE Ratio is now.
What was Bio-Rad Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?
Bio-Rad Laboratories, Inc. EPS is -20.35 EUR over the trailing 12 months.
Which sector does the Bio-Rad Laboratories, Inc. company belong to?
The Bio-Rad Laboratories, Inc. sector is Healthcare.